Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
2.
Rev Port Cardiol ; 15(9): 657-64, 613, 1996 Sep.
Artigo em Português | MEDLINE | ID: mdl-9081319

RESUMO

The authors review the clinical impact of cardiac amyloidosis and new aspects concerning the management of this disease in the literature. Cardiac amyloidosis accounts for 5-10% of non-coronary myocardial disorders. It is a distinct form of cardiomyopathy with a severe prognosis. The authors review the role of endomyocardial biopsy and the relative sensitivity of non-invasive diagnostic methods. Chemical and genetic typing of amyloid, which is of considerable clinical value, is also reviewed due to recent evidence of treatment for different types of systemic and cardiac amyloidosis, such as the most common hereditary form caused by transthyretin gene mutation.


Assuntos
Amiloidose , Cardiomiopatias , Amiloidose/classificação , Amiloidose/diagnóstico , Amiloidose/terapia , Cardiomiopatias/classificação , Cardiomiopatias/diagnóstico , Cardiomiopatias/terapia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA